Korea Chorus Obtains GMP Certification for Sputnik Vaccine Production

Korea Chorus announced on the 27th that it has received a GMP certificate from the Russian Ministry of Industry. (Photo by Korea Chorus)

[Asia Economy Reporter Lee Chun-hee] Korea Corus has received GMP (Good Manufacturing Practice) certification from Russia for the production of the Russian COVID-19 vaccines Sputnik V and Sputnik Light, which it is manufacturing under contract (CMO).

Korea Corus announced on the 27th that it received GMP certification from Russian authorities on the 15th and officially submitted the documentation through the Russian Ministry of Industry on the 22nd. GMP is a certification that confirms a pharmaceutical manufacturer has the appropriate facilities to produce medicines. A Korea Corus official evaluated, "This certification is significant as it is the world's first case of receiving Russian GMP certification for the production of Sputnik vaccines outside Russia."

With the completion of GMP certification, Korea Corus has finished preparing the first shipment of 4.5 million doses of the finished Sputnik Light vaccine product and is sending sample quantities to Russia for pre-shipment quality verification by the Gamaleya Institute. Once shipment approval is granted in Russia, the shipment will proceed, and an additional 3 million doses of finished products will be prepared by the second week of next month to continue regular product exports.